Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial-Reference-Cited by-同舟云学术

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Published:2009-06 Issue:6 Volume:11 Page:611-622
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Jadzinsky M.,Pfützner A.,Paz-Pacheco E.,Xu Z.,Allen E.,Chen R.,

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01056.x/fullpdf

Reference27 articles.

1. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

2. Emerging incretin-based therapies for type 2 diabetes: incretin mimetics and DPP-4 inhibitors;Stonehouse;Curr Diabetes Rev,2008

3. Oral antihyperglycemic therapy for type 2 diabetes: scientific review;Inzucchi;JAMA,2002

4. 10 year follow-up of intensive glucose control in type 2 diabetes. UKPDS 80;Holman;N Engl J Med,2008

5. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action;Drucker;Diabetes Care,2007

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role and Mechanism of Probiotics Supplementation in Blood Glucose Regulation: A Review;Foods;2024-08-27

2. Individual dipeptidyl peptidase‐4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta‐analysis;Basic & Clinical Pharmacology & Toxicology;2024-05-02

3. Adipose tissue inflammation linked to obesity: A review of current understanding, therapies and relevance of phyto-therapeutics;Heliyon;2024-01

4. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review;Frontiers in Endocrinology;2023-12-19

5. Initial Combination Therapy in Type 2 Diabetes;Endocrinology and Metabolism;2023-11-30